We use cookies for a better user experience. Read our Privacy Policy

I Agree

Industry Verticals »

All Categories

Insights »

About TMR »

Cervical Dysplasia Market

Schedule a Call

Cervical Dysplasia Market

Cervical Dysplasia Market (Diagnostic - Tests (Pap Smear Test, HPV Test, Biopsy), Devices (Colposcopy); End User - Hospitals, Diagnostic Centers, Private Gynecologists’ Offices, Research and Academic Institutes, and Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2024

Global Cervical Dysplasia Market – An Overview

The highly consolidated vendor landscape of global cervical dysplasia market is set to drive it to a higher growth curve over the forecast period. A large number of factors of growth will ensure that the market charts a sturdy growth rate from 2017 to 2024. As per Transparency Market Research, valuation of the market would surge, creating a slew of opportunities on its way. A major factor of growth in the global cervical dysplasia market has been an increase in awareness regarding need to take diagnostics tests – cervical cancer screening programs are a major positive factor. Governments are also directing efforts towards this end to ensure better female health and outcomes of medical treatments.

A glimpse into factors that are driving growth in the global dysplasia market is provided below:

  • Impressive opportunities in the market would arise as an outcome of government support provided in a number of countries. Not only is it generating awareness regarding health but also initiating healthcare screening programs on the basis of its own funds. One of the most significant factors that have led to this pro-activeness across the world is the high incidence of cancer noted.
  • Advancement in certain technologies such as those in the field of cytology-based screening is a notable factor of growth in the global cervical dysplasia market. Increase in research and development (R&D) activities will only contribute further to the anticipated growth for the forecast period.
  • Population of females in the reproductive age is increasing and this demands better awareness (often spread as part of initiatives taken by schools and colleges) and better diagnostics tests. This is set to propel notable growth in the global cervical dysplasia market. More women in the workplace also means higher spending capacity for women, set to drive the market forward.

Global Cervical Dysplasia Market: Snapshot

Cervical dysplasia makes for one of the fastest growing market segments in the field of cancer diagnosis and treatment. Cervical cancer is a precancerous stage and it can be completely cured by early detection. Rising consumer awareness in this regard has led to an increased demand for cervical screenings in the past few years. Government bodies in several developed countries conduct screening programs in order to improve the quality of life of population by reducing the mortality rate. Furthermore, recommendations from government organization for early detection of chronic diseases including cervical dysplasia is one of the major factors that is expected to drive the overall cervical dysplasia market over the forecast period.

global cervical dysplasia market

Transparency Market Research states that the global cervical dysplasia market was valued at US$394.0 million in 2017 and will expand at a CAGR of 7.2 % during the period between 2017 and 2024, to reach US$640.2 million by 2024.

Thanks to High Accuracy and Low Cost, HPV Tests to See Vast Rise in Demand

Based on diagnosis, the market has been segmented into diagnostic tests and diagnostic devices. Furthermore, the diagnosis test segment is examined for Pap smear (Papanicolaou) test, HPV (human papillomavirus) test, and biopsy. Colposcope devices are considered as diagnostic devices for cervical dysplasia market in this report. Of these, the segment of diagnostic tests accounted for around 86.3% of the market in terms of revenue in 2015. Availability of reimbursement for cervical dysplasia screening tests in mature markets such as North America and Europe is one of the key factors expected to fuel the sales of cervical dysplasia diagnostic tests market in the next few years.

Of the key cervical dysplasia diagnostic tests analyzed in the report, the segment of HPV tests is expected to grow at a higher CAGR over the forecast period owing to the rising aversion to Pap smear tests and advancements in HPV testing technologies. The significant false-negative rate and high costs of Pap smear tests have resulted in a vast decline in their demand, with the more accurate and cost-effective HPV testing emerging as one of the primary screening tool recommended by healthcare providers these days.

Developed Economies to Continue Being Most Lucrative

Geographically, North America was the dominant market for cervical dysplasia in 2017. The region accounted for a share of over 54.8% of the global cervical dysplasia market in the said year. Rising awareness about cervical dysplasia screening programs and technological advancements in screening devices and other supporting equipment are the key factors fueling the growth of the North America cervical dysplasia market. The diagnosis test segment in North America dominated, accounting for over 85% in the regional market in 2017. The increasing incidence rate of cervical cancer in women above the age of 50 years and favorable reimbursement policies supported by federal organizations such as Medicare are also expected to drive the market in North America in the next few years.

The cervical dysplasia market in Asia Pacific is anticipated to witness the most promising growth rate during the forecast period, chiefly owing to the improving healthcare infrastructure and encouraging government funding on cancer research in the region. The markets in emerging economies such as India and China are expected to exhibit significant expansion in the next few years. Several government-funded cervical dysplasia screening programs in these countries, initiated with the aim of reducing the mortality rate by improving the quality of life of the population will be a key driver of the market.

Some of the key players operating in the global cervical dysplasia market are F. Hoffmann La-Roche Ltd., QIAGEN, Becton, Dickinson and company, OncoHealth Corporation, Quest Diagnostics, Inc., Hologic, Inc., and Abbott Healthcare Pvt. Ltd.

The global cervical dysplasia market is segmented as follows:

Diagnosis
  • Diagnosis Test
    • Pap Smear Test
    • HPV Test
    • Biopsy
  • Diagnostic Device
    • Colposcopy

End User
  • Hospitals
  • Diagnostic Centers
  • Private Gynecologists’ Offices
  • Research & Academic Institutes
  • Ambulatory Surgical Centers

Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa

    Section - 1 Preface 
    1.1 Report Scope and Market Segmentation 
    1.2 Research Highlights

    Section - 2 Assumptions and Research Methodology 
    2.1 Assumptions and Acronyms Used
    2.2 Research Methodology

    Section-3 Executive Summary
    3.1 Global Cervical Dysplasia: Market Snapshot
    3.2 Global Cervical Dysplasia Market: Opportunity Map

    Section-4 Market Overview
    4.1 Global Cervical Dysplasia Market: Key Industry Developments

    Section-5 Market Dynamics
    5.1 Drivers and Restraints Snapshot Analysis
           5.1.2 Drivers
                   5.1.2.1 Increasing cervical screening programs
                   5.1.2.2 Rising Prevalence of Cervical Cancer in aging population
                   5.1.2.3 Government Funding On Cancer Screening Programs
                   5.1.2.4 Favorable Government policies
                   5.1.2.5 Awareness campaigns 
                   5.1.2.6 Increasing Cigarette Smokers around the Globe
                   5.1.2.7 Government organization recommendations
           5.1.3 Restraints
                   5.1.3.1 Low awareness in underdeveloped countries hinders the growth of the market 
                   5.1.3.2 HPV vaccination recommendations
                   5.1.3.3 Changes in Government Policies 
    5.2 Global Cervical Dysplasia Market Revenue Projection
    5.3 Porter’s Five Forces Analysis
    5.4 Cervical Dysplasia Market Outlook

    Section-6 Cervical Dysplasia Market Analysis, By Diagnosis
    6.1 Key Findings
    6.2 Introduction
    6.3 Global Cervical Dysplasia Market Value Share Analysis, By Diagnosis Type
    6.4 Global Cervical Dysplasia Market Forecast, By Diagnosis Type
           6.4.1 Diagnostic Test
                   6.4.1.1. HPV Test
                   6.4.1.2. Pap Smear Test
                   6.4.1.3. Biopsy
           6.4.2 Diagnostic Devcie
    6.4.2.1. Colposcopy
    6.5 Global Cervical Dysplasia Market Attractiveness Analysis, By Diagnosis Type

    Section-7 Global Cervical Dysplasia Market Analysis, By End User
    7.1 Key Findings
    7.2 Introduction
    7.3 Global Cervical Dysplasia Market Value Share Analysis, By End User
    7.4 Global Cervical Dysplasia Market Forecast, By End User
           7.4.1 Hospitals
           7.4.2 Diagnostic Centers
           7.4.3 Ambulatory Surgical Centers
           7.4.4 Private Gynecologist’s Offices
           7.4.5 Research & Academic institutes
    7.5 Global Cervical Dysplasia Market Attractiveness Analysis, By End User

    Section-8 North America Cervical Dysplasia Market Analysis
    8.1 Key Findings
    8.2 North America Cervical Dysplasia Market Overview
    8.3 North America Market Value Share Analysis, By Diagnosis Type
           8.3.1 North America Market Forecast, By Diagnosis Type
    8.4 North America Market Value Share Analysis, By End User
           8.4.1 North America Market Forecast, By End User
    8.5 North America Market Forecast, By Country
    8.6 North America Market Attractiveness Analysis
    8.7 North America Market Trends

    Section-9 Europe Cervical Dysplasia Market Analysis
    9.1 Key Findings
    9.2 Europe Cervical Dysplasia Market Overview
    9.3 Europe Market Value Share Analysis, By Diagnosis Type
           9.3.1 Europe Market Forecast, By Diagnosis Type
    9.4 Europe Market Value Share Analysis, By End User
           9.4.1 Europe Market Forecast, By End User
    9.5 Europe Market Forecast, By Country
    9.6 Europe Market Attractiveness Analysis
    9.7 Europe Market Trends

    Section-10 Asia Pacific Cervical Dysplasia Market Analysis
    10.1 Key Findings
    10.2 Asia Pacific Cervical Dysplasia Market Overview
    10.3 Asia Pacific Market Value Share Analysis, By Diagnosis Type
           10.3.1 Asia Pacific Market Forecast, By Diagnosis Type
    10.4 Asia Pacific Market Value Share Analysis, By End User
           10.4.1 Asia Pacific Market Forecast, By End User
    10.5 Asia Pacific Market Forecast, By Country
    10.6 Asia Pacific Market Attractiveness Analysis
    10.7 Asia Pacific Market Trends

    Section-11 Latin America Cervical Dysplasia Market Analysis
    11.1 Key Findings
    11.2 Latin America Cervical Dysplasia Market Overview
    11.3 Latin America Market Value Share Analysis, By Diagnosis Type
           11.3.1 Latin America Market Forecast, By Diagnosis Type
    11.4 Latin America Market Value Share Analysis, By End User
           11.4.1 Latin America Market Forecast, By End User
    11.5 Latin America Market Forecast, By Country
    11.6 Latin America Market Attractiveness Analysis
    11.7 Latin America Market Trends

    Section-12 Middle East and Africa Cervical Dysplasia Market Analysis
    12.1 Key Findings
    12.2 Middle East and Africa Market Overview
    12.3 Middle East and Africa Market Value Share Analysis, By Diagnosis Type
           12.3.1 Middle East and Africa Market Forecast, By Diagnosis Type
    12.4 Middle East and Africa Market Value Share Analysis, By End User
           12.4.1 Middle East and Africa Market Forecast, By End User
    12.5 Middle East and Africa Market Forecast, By Country
    12.6 Middle East and Africa Market Attractiveness Analysis

    Section-13 Competition Landscape
    13.1. Competition Matrix
    13.2. Company Profiles
           13.2.1. Becton, Dickinson and company.
                   13.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.1.2. Financial Overview
                   13.2.1.3. Diagnosis Portfolio
                   13.2.1.4. SWOT Analysis
                   13.2.1.5. Strategic Overview
           13.2.2 Hologic, Inc
                   13.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.2.2. Financial Overview
                   13.2.2.3. Diagnosis Portfolio
                   13.2.2.4. SWOT Analysis
                   13.2.2.5. Strategic Overview
           13.2.3 Micromedic Technologies Ltd.
                   13.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.3.2. Financial Overview
                   13.2.3.3. Diagnosis Portfolio
                   13.2.3.4. SWOT Analysis
                   13.2.3.5. Strategic Overview
           13.2.4 OncoHealth Corporation 
                   13.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.4.2. Financial Overview
                   13.2.4.3. Diagnosis Portfolio
                   13.2.4.4. SWOT Analysis
                   13.2.4.5. Strategic Overview
           13.2.5 Quest Diagnostics, Inc 
                   13.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.5.2. Financial Overview
                   13.2.5.3. Diagnosis Portfolio
                   13.2.5.4. SWOT Analysis
                   13.2.5.5. Strategic Overview
           13.2.6 F. Hoffmann La-Roche Ltd. 
                   13.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.6.2. Financial Overview
                   13.2.6.3. Diagnosis Portfolio
                   13.2.6.4. SWOT Analysis
                   13.2.6.5. Strategic Overview
           13.2.7 QIAGEN N.V.
                   13.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.7.2. Financial Overview
                   13.2.7.3. Diagnosis Portfolio
                   13.2.7.4. SWOT Analysis
                   13.2.7.5. Strategic Overview
           13.2.8 Abbott Laboratories
                   13.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                   13.2.8.2. Financial Overview
                   13.2.8.3. Diagnosis Portfolio
                   13.2.8.4. SWOT Analysis
                   13.2.8.5. Strategic Overview

    List of Tables

    Table 01: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
    Table 02: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2016–2024
    Table 03: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, by Region, 2015–2024
    Table 04: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Diagnosis Type, 2015–2024
    Table 05: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by End-user, 2015–2024
    Table 06: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, by Country, 2015–2024
    Table 07: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
    Table 08: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
    Table 09: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
    Table 10: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
    Table 11: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
    Table 12: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
    Table 13: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
    Table 14: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024
    Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Diagnosis Type, 2015–2024
    Table 15: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By End User, 2015–2024
    Table 16: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, By Country, 2015–2024

    List of Figures

    Figure01: Global Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
    Figure02: Global Cervical Dysplasia Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
    Figure03: Cervical Dysplasia Market Attractiveness Analysis, By Diagnosis Type
    Figure04: Global Cervical Dysplasia Market Value Share Analysis, by End-user, 2016 and 2024
    Figure05: Cervical Dysplasia Market Attractiveness Analysis, by End-user
    Figure06: Global Cervical Dysplasia Market Value Share Analysis, by Region, 2016 and 2024
    Figure07: Cervical Dysplasia Market Attractiveness Analysis, by Region
    Figure09: North America Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
    Figure10: North America Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
    Figure11: North America Market Attractiveness Analysis, by Country
    Figure12: North America Market Value Share Analysis, by Diagnosis Type, 2016 and 2024
    Figure13: North America Market Value Share Analysis, by End-User, 2016 and 2024
    Figure14: North America Market Value Share Analysis, by Country, 2016 and 2024
    Figure15: North America Market Attractiveness Analysis, by Diagnosis Type 
    Figure16: North America Market Attractiveness Analysis, by End-user
    Figure17: Europe Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
    Figure21: Europe Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
    Figure22: Europe Market Attractiveness Analysis, By Country
    Figure23: Europe Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
    Figure24: Europe Market Value Share Analysis, By End User, 2016 and 2024
    Figure25: Europe Market Value Share Analysis, By Country, 2016 and 2024
    Figure26: Europe Market Attractiveness Analysis, by Diagnosis 
    Figure27: Europe Market Attractiveness Analysis, by End User 
    Figure28: Asia Pacific Cervical Dysplasia Market Size (US$ Mn) and Forecast, 2015–2024
    Figure29: Asia Pacific Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
    Figure30: Asia Pacific Market Attractiveness Analysis, By Country
    Figure31: Asia Pacific Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
    Figure32: Asia Pacific Market Value Share Analysis, By End User, 2016 and 2024
    Figure33: Asia Pacific Market Value Share Analysis, By Country, 2016 and 2024
    Figure34: Asia Pacific Market Attractiveness Analysis, by Diagnosis 
    Figure35: Asia Pacific Market Attractiveness Analysis, by End User 
    Figure36: Latin America Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
    Figure37: Latin America Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
    Figure38: Latin America Market Attractiveness Analysis, By Country
    Figure39: Latin America Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
    Figure40: Latin America Market Value Share Analysis, By End User, 2016 and 2024
    Figure41: Latin America Market Value Share Analysis, By Country, 2016 and 2024
    Figure42: Latin America Market Attractiveness Analysis, by Diagnosis 
    Figure43: Latin America Market Attractiveness Analysis, by End User 
    Figure44: Middle East and Africa Cervical Dysplasia Market Size (US$ Mn) Forecast, 2015–2024
    Figure45: Middle East and Africa Cervical Dysplasia Market Size Y-o-Y Growth Projections, 2015–2024
    Figure46: Middle East and Africa Market Attractiveness Analysis, By Country
    Figure47: Middle East and Africa Market Value Share Analysis, By Diagnosis Type, 2016 and 2024
    Figure48: Middle East and Africa Market Value Share Analysis, By End User, 2016 and 2024
    Figure49: Middle East and Africa Market Value Share Analysis, By Country, 2016 and 2024
    Figure50: Middle East and Africa Market Attractiveness Analysis, by Diagnosis 
    Figure51: Middle East and Africa Market Attractiveness Analysis, by End User 

Google translate

Copyright © Transparency Market Research, Inc. All Rights reserved